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The left ventricular outftow gradient. Obstruction to left
ventricular outflow is an important feature of many patients
with hypertrophic cardiomyopathy that has attracted the
interest of clinicians and students of this disease for more
than 30 years (1-11). Indeed, the nature and significance of
the outflow gradient in hypertrophic cardiomyopathy have
often been the source of controversy and debate (12,13). The
subaortic gradient in this disease appears to reflect a dy-
namic form of obstruction to left ventricular outflow (due to
systolic anterior motion of the mitral valve) (2,5-11) that can
be reduced or augmented by interventions that alter sys-
temic arterial pressure and resistance, myocardial contrac-
tility or ventricular volume. In practical terms, alterations in
the gradient have usually been studied by introducing into
the catheterization laboratory setting certain physiologic or
pharmacologic provocations such as isoproterenol infusion,
amyl nitrite inhalation, Valsalva maneuver or premature
ventricular contraction (2,5,9-11). Increases in the outflow
gradient occur concomitantly with these manuevers and the
magnitude of the provokable gradient has been used to
characterize the hemodynamic state of the patient and to
determine whether operative intervention is justified (14,15).
Responses of the outflow gradient to such laboratory prov-
ocations have been utilized inferentially as if they represent
physiologic mechanisms virtually identical with physiologic
exercise.
The present study. Awareness that our understanding of
the complex nature of the subaortic gradient in hypertrophic
cardiomyopathy is not yet complete is illustrated by the
study in this issue of the Journal by Klues et al. (16) from
Germany. These investigators present novel data that en-
hance our understanding of the mechanisms by which dy-
namic obstruction occurs in this disease. Klues et al. studied
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10 patients with hypertrophic cardiomyopathy and left ven-
tricular outflow obstruction due to systolic anterior motion
of the mitral valve. The average age of the patients was
about 50 years and nine were symptomatic (five eventually
required ventricular septal myotomy-myectomy). Patients
demonstrated a wide range of subaortic gradients under
basal conditions (0 to 89 mm Hg; average 37) that were
exaggerated (to 75 to 175 mm Hg) by provocations such as
the Valsalva maneuver or extrasystolic beats. The effect of
exercise on the outflow gradient was studied with patients in
the supine position with legs elevated. In each patient up to
5 minutes of bicycle exercise induced little or no increase in
the subaortic gradient, despite an appropriate increase in
arterial blood pressure, heart rate and cardiac output (17).
However, in 9 of the 10 patients studied, the gradient
increased rapidly and dramatically almost immediately after
termination of exercise, usually becoming maximal 3 to
5 min into the recovery period; this postexercise increase in
gradient occurred while arterial blood pressure, heart rate
and cardiac output returned to basal levels. Therefore, for
the overall group studied, the mean subaortic gradient was
37 ± 10 mm Hg under basal conditions, 30 ± 10 mm Hg with
exercise and 69 ± 15, 84 ± II and 59 ± 14 mm Hg,
respectively, 1, 3 and 5 min after cessation of exercise.
The authors (16) indicate that the most likely mechanism
by which the outflow gradient develops during recovery is
the rapid change in preload observed after exercise-Le., an
abrupt decrease in venous return (as evidenced by decreased
pulmonary artery and capillary wedge pressures) occurring
with cessation of exercise, resulting in reduced left ventric-
ular volume and a persistent or progressive increase in
intraventricular systolic pressure. During exercise, an in-
crease in pulmonary artery and capillary wedge pressures
prevents substantial reduction in left ventricular volume and
development of outflow obstruction, despite an increase in
myocardial contractility, heart rate and cardiac output and a
reduction in systemic vascular resistance.
Clinical implications. These observations of Klues et al.
(16) are potentially important for several reasons. First, the
described "delay" in onset of the gradient until the recovery
phase deviates from the generally held precept that outflow
obstruction is typically induced during physiologic exercise
in patients with hypertrophic cardiomyopathy. Second, the
data suggest that the changes in magnitude of outflow
obstruction induced in the catheterization laboratory during
certain artificial provocations (Valsalva maneuver, amyl
nitrite inhalation or isoproterenol infusion, for example) may
not necessarily reflect the same mechanisms and alterations
achieved by "pure" physiologic exercise in the supine
position. Third, the behavior of the gradient during and after
exercise reported by Klues et al. (16) raises interesting
considerations regarding the pathophysiology of symptoms
in patients with obstructive hypertrophic cardiomyopathy.
For example, the findings suggest that the development of
exertional dyspnea, chest pain and fatigue may not always
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be intimately related to the presence of an outflow gradient,
and they underline the concept that such symptoms in
patients with hypertrophic cardiomyopathy are usually due
to a complex interaction of pathophysiologic alterations such
as diastolic dysfunction, arrhythmias and myocardial isch-
emia, as well as outflow obstruction (0). On the other hand,
in patients with obstructive hypertrophic cardiomyopathy,
syncope or sudden cardiac death often occurs shortly after
the termination of exercise, suggesting that a marked in-
crease in subaortic gradient during recovery may play an
important role in the genesis of these events. Finally, the
data of Klues et al. (6) suggest that a certain degree of
imprecision may be involved in the characterization of
hemodynamic state (in those patients with hypertrophic
cardiomyopathy considered for operation) by relying on a
variety of provocations in the catheterization laboratory that
may not be directly comparable to the pure physiologic
effects of exercise on dynamic left ventricular outflow tract
obstruction.
Given the acknowledged clinical and morphologic diver-
sity of hypertrophic cardiomyopathy 00,11), it is also not
altogether unexpected that the behavior of outflow obstruc-
tion with exercise may not be identical for all patients within
the broad clinical spectrum of this disease. Many patients
may demonstrate the phenomenon described by Klues et al.
(6) in which augmentation of the gradient is delayed until
the recovery period after termination of exercise. In other
patients exercise may induce an increase in the outflow tract
gradient. Indeed, earlier hemodynamic studies (2-4) in pa-
tients with obstructive hypertrophic cardiomyopathy de-
scribed such heterogeneity in the response of the gradient to
supine exercise, with outflow obstruction developing with
exercise in some patients and during recovery in others.
Conclusions. The left ventricular outflow tract pressure
gradient is an important determinant of the clinical course
and the development of symptoms in many patients with
hypertrophic cardiomyopathy. Understanding the complex
and unique pathophysiologic mechanisms by which the
gradient develops has proved to be an ongoing and evolving
process, even after more than 30 years of study. The most
recent data presented here by Klues et al. (6) will undoubt-
edly contribute further and in a substantial way to our
understanding of the clinical significance of subaortic ob-
struction in patients with hypertrophic cardiomyopathy.
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